Invention Grant
- Patent Title: Pharmaceutical combination comprising a T-type calcium channel blocker
-
Application No.: US16470109Application Date: 2017-12-15
-
Publication No.: US11213517B2Publication Date: 2022-01-04
- Inventor: Melanie Kessler , Catherine Roch
- Applicant: IDORSIA PHARMACEUTICALS LTD
- Applicant Address: CH Allschwil
- Assignee: IDORSIA PHARMACEUTICALS LTD
- Current Assignee: IDORSIA PHARMACEUTICALS LTD
- Current Assignee Address: CH Allschwil
- Agency: Hoxie & Associates LLC
- Priority: WOPCT/EP2016/081455 20161216
- International Application: PCT/EP2017/082981 WO 20171215
- International Announcement: WO2018/109152 WO 20180621
- Main IPC: A61K31/4439
- IPC: A61K31/4439 ; A61P25/08 ; A61K31/20 ; A61K31/4015
Abstract:
The present invention relates to a pharmaceutical combination comprising a first active ingredient which is N-[1-(5-Cyano-pyridin-2-ylmethyl)-1H-pyrazol-3-yl]-2-[4-(1-trifluoromethyl-cyclopropyl)-phenyl]-acetamide or a pharmaceutically acceptable salt thereof and a second active ingredient which has an anti-epileptic effect, or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20200016139A1 PHARMACEUTICAL COMBINATION COMPRISING A T-TYPE CALCIUM CHANNEL BLOCKER Public/Granted day:2020-01-16
Information query
IPC分类:
